Biotech Investing

Nabriva Notches First FDA Nod for Pneumonia Treatment

Biotech Investing

Enlivex Reports Outcome from Sepsis Study

Biotech Investing

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Novavax Up 82 Percent

Biotech Investing

Life Science Big News Roundup: Lexaria Receives Cannabis R&D License; Harvest One Phase II Clinical Trials on Satipharm CBD GelPell® Published in Peer-Reviewed Medical Journal

Life Science Investing

Celgene Receives FDA Approval for INREBIC for Myelofibrosis

Biotech Investing

10 Top Drug Sales to Watch Until 2024

Biotech Investing

Lexaria Bioscience Announces it has Received Four New Patents

Cannabis Investing News

Bion’s Readily-Available Nitrogen Fertilizer Passes Key Hurdle

Biotech Investing

Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome

Biotech Investing

Zosano Pharma Files IND for a Phase 2/3 Clinical Study in Cluster Headache

Biotech Investing

Canna-V-Cell Sciences Inc. Announces Private Placement

Cannabis Investing News

Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors

Cannabis Investing News

Latest biotech News

More biotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES